comprehensive -WSS

comprehensive

author：fashion 2025-09-29 01:36:48 - browse：7

Fran van Delft for Galapagos

Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S.

Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval. The Belgian company framed the collaboration as one that could help overcome the limitations that have held back access to existing CAR-T therapies from other companies.

CAR-Ts have proven to be potent treatments for certain cancers, but they are complicated medicines to make. Immune cells have to be removed from a patient, shipped to specialty sites, where they’re engineered with cancer-killing abilities, and then returned to the hospital for infusion back into patients. The process, which can take weeks if not months, has put a crunch on the number of patients companies and hospitals are able to treat.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： As pharma fights Medicare drug negotiation, hospitals, docs silent

WSS

Judge agrees to delay next hearing in Trump classified documents case

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

What do new weight loss drugs mean for bariatric surgery?

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Pandemic and All Hazards Preparedness Act needs lean update

Drug firms test therapies to halt Alzheimer’s before symptoms arise

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

New air purifier tech could be key to improving indoor air quality

CDC advisory panel says seniors 'may' get RSV vaccine

Continuity nursing helped my family in our darkest PICU moments

Medicare wants to send $9 billion to 340B hospitals

Trump demands the U.S. pay no more for drugs than other countries … again

Winners, losers from Medicare’s list of drugs subject to price talks

What does generative AI mean for health care? We asked experts

Departing Stanford president retracts two papers

Heart attack and stroke risk calculators need revising

Create a giant ice tray with this foil pan hack to keep food cold this summer

Wikipedia

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

How to make Best Hospitals ratings actually useful for patients

Drug firms test therapies to halt Alzheimer’s before symptoms arise

What do new weight loss drugs mean for bariatric surgery?

What AAP's gender

Wikipedia

explore

hotspot

Wikipedia